Nicotine Transdermal System Patch 14 mg
Aveva is recalling 14 mg Nicotine Transdermal System Patches due to elevated levels of oxidative-related impurities.
Stop using the affected patches and contact your healthcare provider or pharmacist for guidance on an alternative smoking cessation product.
Why it was recalled
Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.
How to identify it
Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATORIES, Indianapolis, IN 46268, www.majorpharmaceuticals.com, NDC 0536-5895-88.
Official source
Editorial summary by Recall Canary · last updated 2026-05-27 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification